VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q91451373  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010858.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q91451373‏
024 ‎‡a  0000-0002-5860-2640‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q91451373‏
043 ‎‡c  US‏
100 0 ‎‡a  Timothy M. Schmidt‏ ‎‡c  American hematological oncologist‏ ‎‡9  en‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Timothy M Schmidt‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Agent myeloma has a new weapon from (ch1)Q‏
670 ‎‡a  Author's Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone‏
909 ‎‡a  (orcid) 0000000258602640‏ ‎‡9  1‏
919 ‎‡a  gainofchromosome1qisassociatedwithearlyprogressioninmultiplemyelomapatientstreatedwithlenalidomidebortezomibanddexamethasone‏ ‎‡A  Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone‏ ‎‡9  1‏
919 ‎‡a  agentmyelomahasanewweaponfromch1q‏ ‎‡A  Agent myeloma has a new weapon from (ch1)Q‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
947 ‎‡a  US‏ ‎‡9  1‏
996 ‎‡2  BIBSYS|3059495
996 ‎‡2  NUKAT|n 2022060668
996 ‎‡2  DNB|1152418769
996 ‎‡2  DNB|1144633567
996 ‎‡2  ISNI|0000000040643925
996 ‎‡2  DNB|1015469299
996 ‎‡2  CAOONL|ncf10614130
996 ‎‡2  DNB|1080184783
996 ‎‡2  ISNI|0000000060129333
996 ‎‡2  DNB|1080963626
996 ‎‡2  DNB|134950615
996 ‎‡2  DNB|1102251666
996 ‎‡2  DNB|1171341334
996 ‎‡2  NTA|071806555
996 ‎‡2  DNB|1143984188
996 ‎‡2  BIBSYS|90756594
996 ‎‡2  DE633|pe30031205
996 ‎‡2  LC|no2012064586
996 ‎‡2  DNB|1026739640
996 ‎‡2  LC|n 2008044889
996 ‎‡2  BAV|495_381397
996 ‎‡2  DBC|87097992076741
996 ‎‡2  LC|n 2003019806
996 ‎‡2  LC|n 2009029387
996 ‎‡2  LC|n 2019036594
996 ‎‡2  ISNI|0000000407956136
996 ‎‡2  ISNI|0000000382366390
996 ‎‡2  LC|n 2005038305
996 ‎‡2  DNB|104757618X
996 ‎‡2  PLWABN|9811299244305606
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏